Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Generated: May 29, 2017

DrugPatentWatch Database Preview

Propafenone hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic sources for propafenone hydrochloride and what is the scope of propafenone hydrochloride patent protection?

Propafenone hydrochloride
is the generic ingredient in three branded drugs marketed by Mylan Pharms Inc, Watson Labs, Glaxosmithkline Llc, Vintage Pharms, Par Pharm, Orion Corp Orion, Ani Pharms Inc, Watson Labs Inc, Nesher Pharms, and Sun Pharm Inds, and is included in eleven NDAs. There is one patent protecting this compound and two Paragraph IV challenges. Additional information is available in the individual branded drug profile pages.

There are eleven drug master file entries for propafenone hydrochloride. Twenty suppliers are listed for this compound.

Summary for Generic Name: propafenone hydrochloride

Drug Master File Entries: see list11
Suppliers / Packagers: see list20
Bulk Api Vendors: see list37
Clinical Trials: see list994
Patent Applications: see list663
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:propafenone hydrochloride at DailyMed

Pharmacology for Ingredient: propafenone hydrochloride

Drug ClassAntiarrhythmic
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Orion Corp Orion
propafenone hydrochloride
TABLET;ORAL202445-002May 11, 2016ABRXNoNo► Subscribe► Subscribe
Vintage Pharms
propafenone hydrochloride
TABLET;ORAL075938-002Oct 17, 2002ABRXNoNo► Subscribe► Subscribe
Mylan Pharms Inc
propafenone hydrochloride
CAPSULE, EXTENDED RELEASE;ORAL203803-003Apr 29, 2016ABRXNoNo► Subscribe► Subscribe
Watson Labs Inc
propafenone hydrochloride
CAPSULE, EXTENDED RELEASE;ORAL202688-002Aug 24, 2015ABRXNoNo► Subscribe► Subscribe
Watson Labs Inc
propafenone hydrochloride
CAPSULE, EXTENDED RELEASE;ORAL202688-001Aug 24, 2015ABRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Identify first generic entrants
  • Uncover prior art in abandoned patent applications and expired patents
  • Drug patents and clinical trials in dozens of countries

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:

Google Plus